Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,146,674
-$952,821 QoQ
Shares Held
4,515
-47.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,882
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $15,181,531 across 16 Drug Manufacturers - General names. JNJ ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,744 | $5,690,096 | |
| 2 | ABBV |
AbbVie Inc.
|
13,684 | $3,443,441 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,850 | $1,265,725 | |
| 4 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
4,515 | $1,146,674 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,971 | $754,376 | |
| 7 | PFE |
Pfizer Inc
|
21,218 | $510,929 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,810 | $334,772 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,146,674 | 4,515 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,099,495 | 8,589 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $2,099,093 | 10,143 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,828,797 | 9,863 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,467,927 | 9,610 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,094,875 | 6,602 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,098,244 | 7,594 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,320,464 | 8,148 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,227,159 | 8,396 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,304,118 | 8,244 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,568,653 | 10,008 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,365,531 | 15,188 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,842,143 | 17,171 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $2,634,535 | 16,997 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $3,173,340 | 17,964 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $2,896,209 | 17,729 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $3,096,839 | 17,446 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $2,395,086 | 13,514 | Shares | Sole | 2023-12-13 | |
| 2021-12-31 | $2,006,308 | 11,728 | Shares | Sole | 2023-12-13 | |
| 2021-09-30 | $1,949,466 | 12,071 | Shares | Sole | 2023-12-13 | |
| 2021-06-30 | $2,349,357 | 14,261 | Shares | Sole | 2023-12-13 | |
| 2021-03-31 | $1,922,566 | 11,698 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,969,925 | 12,517 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $1,643,337 | 11,038 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $1,371,283 | 9,751 | Shares | Sole | 2021-05-18 | |
| 2020-03-31 | $1,263,568 | 9,636 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||